Patents

US 12605372 B2: Combination therapy for the treatment of cancer

Granted
2026-04-21
Filed
2022-11-09 application 17983762
Type
Utility · 19 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab. Additionally, provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab and dexamethasone.

Source: PTBLXML, file of 2026-04-21 (ipgb20260421.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Celgene Corporation 413 patentsUS company or organizationSummit, NJPTBLXML, file of 2026-04-21

Inventors

InventorPlacePatentsPerson pageSource
Michael D. AmatangeloMadison, NJPTBLXML, file of 2026-04-21
Chad BjorklundSummit, NJ3PTBLXML, file of 2026-04-21
Anjan ThakurtaBasking Ridge, NJ7PTBLXML, file of 2026-04-21
Xiankang HongBridgewater, NJ2PTBLXML, file of 2026-04-21
Mariana CotaSummit, NJ2PTBLXML, file of 2026-04-21

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/45PTBLXML, file of 2026-04-21
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/00PTBLXML, file of 2026-04-21

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-03-20Assignment
Assignment of assignor's interest
AMATANGELO, MICHAEL D. signed 2019-11-13
BJORKLUND, CHAD signed 2019-11-13
THAKURTA, ANJAN signed 2019-11-13
HONG, XIANKANG signed 2019-11-19
COTA, MARIANA signed 2019-11-19
CELGENE CORPORATION SUMMIT, NJ74144/521PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.